Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907086 · ClinicalTrials.gov registry record
Circulating Tumor Material in Colorectal Cancer and Melanoma
A clinical trial of Colorectal Cancer and Melanoma, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT02907086 is a study of Colorectal Cancer and Melanoma that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 7 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02907086, a study of Colorectal Cancer and Melanoma, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
Conditions Studied
Interventions
- OTHER blood collection
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-07-07 |
| Est. Completion | 2020-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907086
The ClinicalTrials.gov registry entry for NCT02907086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer and Melanoma appearing as the primary indexed condition, and to 1 intervention - of which blood collection is the first listed.
NCT02907086 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02907086 about?
NCT02907086 is a clinical study titled "Circulating Tumor Material in Colorectal Cancer and Melanoma". Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
What is the current status of trial NCT02907086?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2017-07-07. Estimated completion is 2020-07-01.
What conditions does trial NCT02907086 study?
This clinical trial studies the following conditions: Colorectal Cancer and Melanoma.
What interventions are being tested in trial NCT02907086?
The interventions under investigation include: blood collection (OTHER).
Who is sponsoring clinical trial NCT02907086?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02907086 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.